IRIS Accounts Production v24.2.0.383 08965521 director 1.4.23 31.7.24 31.7.24 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh089655212023-03-31089655212024-07-31089655212023-04-012024-07-31089655212022-03-31089655212022-04-012023-03-31089655212023-03-3108965521ns15:EnglandWales2023-04-012024-07-3108965521ns14:PoundSterling2023-04-012024-07-3108965521ns10:Director12023-04-012024-07-3108965521ns10:PrivateLimitedCompanyLtd2023-04-012024-07-3108965521ns10:SmallEntities2023-04-012024-07-3108965521ns10:AuditExempt-NoAccountantsReport2023-04-012024-07-3108965521ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-07-3108965521ns10:SmallCompaniesRegimeForAccounts2023-04-012024-07-3108965521ns10:FullAccounts2023-04-012024-07-3108965521ns10:OrdinaryShareClass12023-04-012024-07-3108965521ns10:OrdinaryShareClass22023-04-012024-07-3108965521ns10:RegisteredOffice2023-04-012024-07-3108965521ns5:CurrentFinancialInstruments2024-07-3108965521ns5:CurrentFinancialInstruments2023-03-3108965521ns5:ShareCapital2024-07-3108965521ns5:ShareCapital2023-03-3108965521ns5:RetainedEarningsAccumulatedLosses2024-07-3108965521ns5:RetainedEarningsAccumulatedLosses2023-03-3108965521ns5:FurnitureFittings2023-04-012024-07-3108965521ns5:ComputerEquipment2023-04-012024-07-3108965521ns5:FurnitureFittings2023-03-3108965521ns5:ComputerEquipment2023-03-3108965521ns5:FurnitureFittings2024-07-3108965521ns5:ComputerEquipment2024-07-3108965521ns5:FurnitureFittings2023-03-3108965521ns5:ComputerEquipment2023-03-3108965521ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3108965521ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3108965521ns10:OrdinaryShareClass12024-07-3108965521ns10:OrdinaryShareClass22024-07-31
REGISTERED NUMBER: 08965521 (England and Wales)















Unaudited Financial Statements

for the Period 1 April 2023 to 31 July 2024

for

JE Cardiac Services Ltd

JE Cardiac Services Ltd (Registered number: 08965521)






Contents of the Financial Statements
for the Period 1 April 2023 to 31 July 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


JE Cardiac Services Ltd

Company Information
for the Period 1 April 2023 to 31 July 2024







DIRECTOR: Dr J Easaw





REGISTERED OFFICE: 30 Gay Street
Bath
Somerset
BA1 2PA





REGISTERED NUMBER: 08965521 (England and Wales)





ACCOUNTANTS: Moore
Chartered Accountants
30 Gay Street
Bath
BA1 2PA

JE Cardiac Services Ltd (Registered number: 08965521)

Balance Sheet
31 July 2024

31.7.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,856 2,771

CURRENT ASSETS
Debtors 5 127,966 150,369
Investments 6 4,319 239,719
Cash at bank 378,834 29,125
511,119 419,213
CREDITORS
Amounts falling due within one year 7 49,890 55,525
NET CURRENT ASSETS 461,229 363,688
TOTAL ASSETS LESS CURRENT
LIABILITIES

463,085

366,459

CAPITAL AND RESERVES
Called up share capital 8 102 102
Retained earnings 462,983 366,357
SHAREHOLDERS' FUNDS 463,085 366,459

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

JE Cardiac Services Ltd (Registered number: 08965521)

Balance Sheet - continued
31 July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 October 2024 and were signed by:





Dr J Easaw - Director


JE Cardiac Services Ltd (Registered number: 08965521)

Notes to the Financial Statements
for the Period 1 April 2023 to 31 July 2024

1. STATUTORY INFORMATION

JE Cardiac Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Computer equipment - 33% on reducing balance

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

JE Cardiac Services Ltd (Registered number: 08965521)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 31 July 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2023
and 31 July 2024 206 8,025 8,231
DEPRECIATION
At 1 April 2023 52 5,408 5,460
Charge for period 51 864 915
At 31 July 2024 103 6,272 6,375
NET BOOK VALUE
At 31 July 2024 103 1,753 1,856
At 31 March 2023 154 2,617 2,771

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.3.23
£    £   
Trade debtors 15,735 37,507
Other debtors 112,231 112,862
127,966 150,369

6. CURRENT ASSET INVESTMENTS
31.7.24 31.3.23
£    £   
Listed investments 4,319 239,719

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.3.23
£    £   
Taxation and social security 48,290 54,025
Other creditors 1,600 1,500
49,890 55,525

JE Cardiac Services Ltd (Registered number: 08965521)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 31 July 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.3.23
value: £    £   
100 A Ordinary £1 100 100
2 B Ordinary £1 2 2
102 102

9. RELATED PARTY DISCLOSURES

Included in debtors is £83,911 (2023: £78,759) owed by Dr J Easaw, a director of the company. Interest is being charged on the amount at the official rate.